Release Notes: Version 20240412
About this release
This release (version 20240412) provides the latest updates to the Canadian Clinical Drug Data Set in English and French. A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here.
There is no change to the Technical Specification or the Editorial Guidelines.
The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.
Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.
General Notes
The following files are available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT),
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release reflects additions and changes that have occurred in DPD since the last CCDD release.
Non-proprietary Therapeutic Product (NTP)
There are 2 new deprecated concepts in this version, with the first concept resulting from a unit of presentation correction and the second concept resulting from a change in representation of strength from presentation to concentration strength.
ntp_code | ntp_formal_name | ntp_fr_description | Change | New ntp_code | New ntp_formal_name | New ntp_fr_description |
9000005 | epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection ampoule | épinéphrine (chlorhydrate d'épinéphrine) 30 mg par 30 mL solution injectable ampoule | Deprecated | 9015026 | epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection vial | épinéphrine (chlorhydrate d'épinéphrine) 30 mg par 30 mL solution injectable fiole |
9014842 | ranibizumab 2.3 mg per 0.23 mL solution for injection vial | ranibizumab 2,3 mg par 0,23 mL solution injectable fiole | Deprecated | 9012754 | ranibizumab 10 mg per mL solution for injection 0.23 mL vial | ranibizumab 10 mg par mL solution injectable 0,23 mL fiole |
Manufactured Product (MP)
The new deprecated NTPs shown above resulted in the following MP formal name changes.
mp_code | mp_formal_name March Release | mp_fr_description March Release | New mp_formal_name April Release | New mp_fr_description April Release |
77700212 | ADRENALIN (epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection ampoule) SEARCHLIGHT PHARMA INC | ADRENALIN (épinéphrine (chlorhydrate d'épinéphrine) 30 mg par 30 mL solution injectable ampoule) SEARCHLIGHT PHARMA INC | ADRENALIN (epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection vial) SEARCHLIGHT PHARMA INC | ADRENALIN (épinéphrine (chlorhydrate d'épinéphrine) 30 mg par 30 mL solution injectable fiole) SEARCHLIGHT PHARMA INC |
02525852 | BYOOVIZ (ranibizumab 2.3 mg per 0.23 mL solution for injection vial) SAMSUNG BIOEPIS CO., LTD | BYOOVIZ (ranibizumab 2.3 mg par 0,23 mL solution injectable fiole) SAMSUNG BIOEPIS CO., LTD | BYOOVIZ (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) SAMSUNG BIOEPIS CO., LTD | BYOOVIZ (ranibizumab 10 mg par mL solution injectable 0,23 mL fiole) SAMSUNG BIOEPIS CO., LTD |
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]